Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2012
03/01/2012WO2011143218A9 Plant-derived formulations for treatment of hiv
03/01/2012WO2011140128A3 Nail discoloration and fungus treatment
03/01/2012WO2011140126A3 Nail discoloration and fungus treatment
03/01/2012WO2011130301A9 Method of diagnosing and treating melioidosis
03/01/2012WO2011119628A3 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
03/01/2012WO2011106100A3 Method of inducing the production of protective anti-hiv-1 antibodies
03/01/2012WO2011060534A8 Trim5alpha mutants and uses thereof
03/01/2012WO2003053332A3 Composition and method for treating viral infection
03/01/2012US20120054879 HCV Coreceptor and Methods of Use Thereof
03/01/2012US20120053509 Vaccines for human papilloma virus and methods for using the same
03/01/2012US20120053451 Methods and systems for prolonged localization of drug delivery
03/01/2012US20120053242 Compositions rich in omega-3 fatty acids with a low content in phytanic acid
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120053231 Prevention and treatment of nosema disease in bees
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053226 Design of oligonucleotide analogs as therapeutic agents
03/01/2012US20120053223 Compositions and methods for treating retrovirus infections
03/01/2012US20120053219 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/01/2012US20120053213 2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside hiv reverse transcriptase, preparation methods and uses thereof
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053199 Noscapine and analogs and methods related thereto
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053148 Inhibitors of hepatitis c virus
03/01/2012US20120053144 Cobalamin Taxane Bioconjugates For Treating Eye Disease
03/01/2012US20120053139 Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
03/01/2012US20120053116 Scytovirin domain 1 related polypeptides
03/01/2012US20120053115 Lantibiotic Carboxyamide Derivatives With Enhanced Antibacterial Activity
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120052292 Novel medical device coatings
03/01/2012US20120052140 Water-soluble antiviral product containing aframomum melegueta, for the treatment and prevention of acquired immunodeficiency syndrome (aids)
03/01/2012US20120052124 Silk fibroin systems for antibiotic delivery
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052104 Polypeptides and Antibacterial or Antiseptic Use of Same
03/01/2012US20120052099 Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles
03/01/2012US20120052097 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
03/01/2012US20120052095 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
03/01/2012US20120052093 Compositions and methods for preventing and treating uterine disease
03/01/2012US20120052092 Vaccine compositions comprising a mutated factor h binding protein
03/01/2012US20120052090 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
03/01/2012US20120052089 Newcastle disease virus vectored herpesvirus vaccines
03/01/2012US20120052088 Pneumococcal vaccine and uses thereof
03/01/2012US20120052087 Siderophore Conjugate Immunogenic Compositions and Vaccines
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052083 MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL
03/01/2012US20120052082 Cross-protective influenza vaccine
03/01/2012US20120052077 Therapeutic modulation of vaginal epithelium boundary lubrication
03/01/2012US20120052074 Human monoclonal antibodies to activin receptor-like kinase-1
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052070 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/01/2012US20120052050 Use of specific lactic bacteria for the preparation of immunomodulating compositions
03/01/2012US20120052048 Antibacterial phage, phage peptides and methods of use thereof
03/01/2012US20120052046 Phosphoramidate Derivatives of Guanosine Nucleoside Compunds for Treatment of Viral Infections
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
03/01/2012US20120052040 Polymer compositions and methods for their use
03/01/2012US20120052026 Oral compositions containing biphenol antibacterial compounds
03/01/2012US20120052025 Borinic compositions
03/01/2012US20120052005 Combination therapy to improve drug efficiency
03/01/2012CA2809261A1 Potent and selective inhibitors of hepatitis c virus
03/01/2012CA2809093A1 Compositions and uses of materials with high antimicrobial activity and low toxicity
02/2012
02/29/2012EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same
02/29/2012EP2423328A2 Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
02/29/2012EP2423319A1 Novel compound amycolamicin, method for production thereof, and use thereof
02/29/2012EP2423228A1 Antibody containing igg2 having amino acid mutation introduced therein
02/29/2012EP2423213A1 Preparation and use of novel antibiotic, anticancer compounds and derivatives thereof
02/29/2012EP2422791A1 Antiviral phosphinate compounds
02/29/2012EP2422790A1 Paramyxovirus family inhibitors and methods of use thereof
02/29/2012EP2422781A1 Resistance-repellent retroviral protease inhibitors
02/29/2012EP2422780A1 Resistance-repellent retroviral protease inhibitors
02/29/2012EP2421970A1 Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon
02/29/2012EP2421877A1 Anionic conjugates of glycosylated bacterial metabolite
02/29/2012EP2421869A1 Rifamycin derivatives
02/29/2012EP2421858A1 Thioxanthene derivatives for the treatment of infectious diseases
02/29/2012EP2421855A1 Diaryl ethers
02/29/2012EP2421846A1 5-alkynyl-pyridines
02/29/2012EP2421845A1 Antiviral compounds and uses thereof
02/29/2012EP2421831A1 Heterocyclic antiviral compounds
02/29/2012EP2421546A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
02/29/2012EP2421539A1 Methods of treating a pulmonary bacterial infection using fluoro-quinolones
02/29/2012EP2421531A1 Use of nifuratel to treat infections caused by atopobium species
02/29/2012EP2421529A2 Siderophore conjugate immunogenic compositions and vaccines
02/29/2012EP2421527A1 Methods for improving pharmacokinetics
02/29/2012EP2421505A2 Hydrogels for combinatorial delivery of immune-modulating biomolecules
02/29/2012EP2421496A1 Emulsions for transdermal delivery
02/29/2012EP2368989A9 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
02/29/2012EP2176255B1 Andrographolide derivatives and use thereof in manufacture of medicaments
02/29/2012EP2049116B1 Hepatitis c virus inhibitors
02/29/2012EP2039686B1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases
02/29/2012EP1532153B1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/29/2012EP1465642B1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
02/29/2012EP1390383B1 Antisense permeation enhancers
02/29/2012EP1325133B1 Bvh-a2 and bvh-a3 antigens of group b streptococcus
02/29/2012EP1311269B1 Method of using diketopiperazines and composition containing them
02/29/2012CN1994374B Preparation method of papermulberry extract
02/29/2012CN1947747B Traditional Chinese medicine composition containing luteolin and capsule of sweeping forsythia and its preparation method and use
02/29/2012CN1939414B Medicinal composition with antibacterial and anti-inflammation functions
02/29/2012CN1908010B Furin enzyme inhibitor of resisting HIV-1 and preparation method thereof
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102363784A Ruditapes philippinarum Defensin B gene, its recombinant protein and application
02/29/2012CN102363783A Venerupis philippinarum defensin A gene, and recombinant protein and application thereof
02/29/2012CN102363770A Recombinant baculovirus capable of expressing porcine circovirus type 2 Cap protein and somatostatin in fusion manner, and subunit vaccine thereof
1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 1798